Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells

The extracellular matrix component biglycan (BGN) plays an essential role in various physiological and pathophysiological processes. A deficient BGN expression associated with reduced immunogenicity was found in HER-2/neu-overexpressing cells. To determine whether BGN is suppressed by oncogene-drive...

Descripción completa

Detalles Bibliográficos
Autores principales: Subbarayan, Karthikeyan, Massa, Chiara, Leisz, Sandra, Steven, André, Bethmann, Daniel, Biehl, Katharina, Wickenhauser, Claudia, Seliger, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067524/
https://www.ncbi.nlm.nih.gov/pubmed/35529675
http://dx.doi.org/10.1080/2162402X.2022.2069214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067524/
https://www.ncbi.nlm.nih.gov/pubmed/35529675
http://dx.doi.org/10.1080/2162402X.2022.2069214

Ejemplares similares